Edmond de Rothschild Holding’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Edmond de Rothschild Holding’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,605	Closed	-$595K	–	815
2021 Q1	$595K	Sell	14,605 -3,274	-18%	-$150K	0.02%	370
2020 Q4	$774K	Buy	17,879 +5,029	+39%	+$248K	0.03%	317
2020 Q3	$709K	Buy	12,850 +813	+7%	+$51.7K	0.03%	285
2020 Q2	$760K	Sell	12,037 -6,178	-34%	-$424K	0.03%	256
2020 Q1	$931K	Buy	18,215 +6,475	+55%	+$434K	0.05%	218
2019 Q4	$933K	Sell	11,740 -1,626	-12%	-$96.4K	0.04%	248
2019 Q3	$649K	Buy	13,366 +448	+3%	+$23.3K	0.03%	287
2019 Q2	$679K	Buy	+12,918	New	+$742K	0.03%	268

Other funds holding GBT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Edmond de Rothschild Holding's GBT Position: Q2 2021 in Review

Edmond de Rothschild Holding sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 14,605 shares — an estimated $595K sold.

Edmond de Rothschild Holding first reported a position in GBT in Q2 2019 and held it in 8 quarters. The position peaked at $933K in Q4 2019. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

Edmond de Rothschild Holding reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Edmond de Rothschild Holding sold 14,605 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $595K.
Edmond de Rothschild Holding first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 8 quarters.
Edmond de Rothschild Holding's Global Blood Therapeutics, Inc. position peaked at $933K in Q4 2019.
191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2021, filed 11 Aug 2021.